Trans-scleral delivery of antiangiogenic proteins

Journal of Ocular Pharmacology and Therapeutics

Volumn 24, Issue 1, 2008, Pages 70-79

  Demetriades, Anna M ^a   Deering, Tye ^a   Liu, Hansheng ^a   Lu, Lili ^a   Gehlbach, Peter ^a   Packer, Jonathan D ^a   Gabhann, Feilim Mac ^a   Popel, Aleksander S ^a   Wei, Lisa L ^b   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENVEC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; PIGMENT EPITHELIUM DERIVED FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN RECEPTOR 1;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CHOROID; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE; FEMALE; MOUSE; NONHUMAN; PARTICLE SIZE; PIGMENT EPITHELIUM; PROTEIN BINDING; PROTEIN EXPRESSION; RETINA; SCLERA;

ADENOVIRIDAE; ANGIOGENESIS INHIBITORS; ANIMALS; CHOROID; DRUG DELIVERY SYSTEMS; EYE PROTEINS; FEMALE; GENE THERAPY; GREEN FLUORESCENT PROTEINS; INJECTIONS; MICE; MICE, INBRED C57BL; NERVE GROWTH FACTORS; RECOMBINANT PROTEINS; RETINA; SCLERA; SERPINS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VITREOUS BODY;

EID: 38549113408     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2007.0061     Document Type: Article

References (22)

1. Aiello, L.P., Pierce, E.A., Foley, E.D., et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. U.S.A. 92:10457-10461, 1995.
2. Adamis, A.P., Shima, D.T., Tolentino, M.J., et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization. Arch. Ophthalmol. 114:66-71, 1996.
3. Okamoto, N., Tobe, T., Hackett, S.F., et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization. Am. J. Pathol. 151:281-291, 1997.
4. Kwak, N., Okamoto, N., Wood, J.M., et al. VEGF is an important stimulator in a model of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 41: 3158-3164, 2000.
5. Ozaki, H., Seo, M.-S., Ozaki, K., et al. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am. J. Pathol. 156:679-707, 2000.
6. Kryzstolik, M.G., Afshari, M.A., Adamis, A.P., et al. Prevention of experimental choroidal neovascularization with intravitreal antivascular endothelial growth factor antibody fragment. Arch. Ophthalmol. 120:338-346, 2002.
7. Rosenfeld, P.J., Brown, D.M., Heier, J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355:1419-1431, 2006.
8. Brown, D.M., Kaiser, P.K., Michels, M., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 355: 1432-1444, 2006.
9. Campochiaro, P.A. Molecular targets for retinal vascular diseases. J. Cell Physiol. 210:575-581, 2007.
10. Gehlbach, P., Demetriades, A.M., Yamamoto, S., et al. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene. Ther. 10:637-646, 2003.
11. Gehlbach, P., Demetriades, A.M., Yamamoto, S., et al. Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and VEGF-induced breakdown of the blood-retinal barrier. Hum. Gene. Ther. 14:129-141, 2003.
12. Saishin, Y., Silva, R.L., Saishin, Y., et al. Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye. Hum. Gene. Ther. 16:473-478, 2005.
13. Brough, D.E., Lizonova, A., Hsu, C., et al. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J. Virol. 70:6497-6501, 1996.
14. Mori, K., Duh, E., Gehlbach, P., et al.: Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J. Cell. Physiol. 188:253-263, 2001.
15. Mori, K., Gehlbach, P., Ando, A., et al. Intraocular adenoviral vector-mediated gene transfer is increased in proliferative retinopathies. Invest. Ophthalmol. Vis. Sci. 43:1610-1615, 2002.
16. Mori, K., Ando, A., Gehlbach, P., et al. Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. Am. J. Pathol. 159:313-320, 2001.
17. Alberdi, E., Aymerich, M.S., and Becerra, S.P. Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons. Evidence for a PEDF receptor. J. Biol. Chem. 274: 31605-31612, 1999.
18. Aymerich, M.S., Alberid, E.M., Martinez, A., et al. Evidence of pigment epithelium-derived factor receptors in the neural retina. Invest. Ophthalmol. Vis. Sci. 42:3287-3293, 2001.
19. Alberdi, E.M., Weldon, J.E., and Becerra, S.P. Glycosaminoglycans in human retinoblastoma cells: Heparan sulfate, a modulator of the pigment epithelium-derived factor-receptor interactions. BMC Biochem. 4:1-9, 2003.
20. MacGabhann, F., Demetriades, A.M., Deering, T., et al. Protein transport to choroid and retina following periocular injection: Theoretical and experimental study. Ann. Biomed. Eng. 35:615-630, 2007.
21. Bron, A.J., Tripathi, R.C., and Tripathi, B.J. Wolff's Anatomy of the Eye and Orbit. London: Chapman and Hall, 1997:217-219.
22. Lima e Silva, R., Kachi, S., Akiyama, H., et al. Transscleral delivery of polyamine analogs for ocular neovascularization. Exp. Eye Res. 83:1260-1267, 2006.